_id

690db32fccc777a4e85d0cc5

Ticker

AURA

Name

Aura Biosciences Inc

Exchange

NASDAQ

Address

80 Guest Street, Boston, MA, United States, 02135

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.aurabiosciences.com

Description

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Last Close

6.51

Volume

317017

Current Price

6.54

Change

0.46082949308756144

Last Updated

2025-11-28T12:33:42.782Z

Image

data:image/webp;base64,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

Ipo Date

2021-10-29T00:00:00.000Z

Market Cap

405150848

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.845

Sentiment Sources

2

Rating

4.5714

Target Price

19.4

Strong Buy

4

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

300000

Gross Profit

-300000

Operating Expenses

27606000

Operating Income

-27906000

Interest Expense

-

Pretax Income

-26104000

Net Income

-26130000

Eps

-0.39628933653187715

Dividends Per Share

-

Shares Outstanding

63503269

Income Tax Expense

26000

EBITDA

-25804000

Operating Margin

-

Total Other Income Expense Net

1802000

Cash

47553000

Short Term Investments

114313000

Receivables

-

Inventories

-

Total Current Assets

170120000

Property Plant Equipment

18859000

Total Assets

190024000

Payables

1888000

Short Term Debt

3220000

Long Term Debt

-

Total Liabilities

33357000

Equity

156667000

Depreciation

280000

Change In Working Capital

1963000

Cash From Operations

-20144000

Capital Expenditures

45000

Cash From Investing

-44019000

Cash From Financing

4363000

Net Change In Cash

-59814000

PE

-

PB

2.75249947263942

ROE

-16.67868791768528

ROA

-13.75089462383699

FCF

-20189000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

300000

Quarters > 0 > income Statement > gross Profit

-300000

Quarters > 0 > income Statement > operating Expenses

27606000

Quarters > 0 > income Statement > operating Income

-27906000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-26104000

Quarters > 0 > income Statement > net Income

-26130000

Quarters > 0 > income Statement > eps

-0.39628933653187715

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

65936672

Quarters > 0 > income Statement > income Tax Expense

26000

Quarters > 0 > income Statement > EBITDA

-25804000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1802000

Quarters > 0 > balance Sheet > cash

47553000

Quarters > 0 > balance Sheet > short Term Investments

114313000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

170120000

Quarters > 0 > balance Sheet > property Plant Equipment

18859000

Quarters > 0 > balance Sheet > total Assets

190024000

Quarters > 0 > balance Sheet > payables

1888000

Quarters > 0 > balance Sheet > short Term Debt

3220000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

33357000

Quarters > 0 > balance Sheet > equity

156667000

Quarters > 0 > cash Flow > net Income

-26130000

Quarters > 0 > cash Flow > depreciation

280000

Quarters > 0 > cash Flow > change In Working Capital

1963000

Quarters > 0 > cash Flow > cash From Operations

-20144000

Quarters > 0 > cash Flow > capital Expenditures

45000

Quarters > 0 > cash Flow > cash From Investing

-44019000

Quarters > 0 > cash Flow > cash From Financing

4363000

Quarters > 0 > cash Flow > net Change In Cash

-59814000

Quarters > 0 > ratios > PE

-0.39628933653187715

Quarters > 0 > ratios > PB

2.75249947263942

Quarters > 0 > ratios > ROE

-16.67868791768528

Quarters > 0 > ratios > ROA

-13.75089462383699

Quarters > 0 > ratios > FCF

-20189000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

300000

Quarters > 1 > income Statement > gross Profit

-300000

Quarters > 1 > income Statement > operating Expenses

28313000

Quarters > 1 > income Statement > operating Income

-28613000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-26971000

Quarters > 1 > income Statement > net Income

-27019000

Quarters > 1 > income Statement > eps

-0.46571861784077206

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

58015718

Quarters > 1 > income Statement > income Tax Expense

48000

Quarters > 1 > income Statement > EBITDA

-26671000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1642000

Quarters > 1 > balance Sheet > cash

107367000

Quarters > 1 > balance Sheet > short Term Investments

69944000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

183958000

Quarters > 1 > balance Sheet > property Plant Equipment

19486000

Quarters > 1 > balance Sheet > total Assets

204397000

Quarters > 1 > balance Sheet > payables

1286000

Quarters > 1 > balance Sheet > short Term Debt

3196000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

29768000

Quarters > 1 > balance Sheet > equity

174629000

Quarters > 1 > cash Flow > net Income

-27019000

Quarters > 1 > cash Flow > depreciation

286000

Quarters > 1 > cash Flow > change In Working Capital

2027000

Quarters > 1 > cash Flow > cash From Operations

-20774000

Quarters > 1 > cash Flow > capital Expenditures

39000

Quarters > 1 > cash Flow > cash From Investing

19977000

Quarters > 1 > cash Flow > cash From Financing

69929000

Quarters > 1 > cash Flow > net Change In Cash

69141000

Quarters > 1 > ratios > PE

-0.46571861784077206

Quarters > 1 > ratios > PB

2.1727364625577654

Quarters > 1 > ratios > ROE

-15.472229698389157

Quarters > 1 > ratios > ROA

-13.218882860315952

Quarters > 1 > ratios > FCF

-20813000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

291000

Quarters > 2 > income Statement > gross Profit

-291000

Quarters > 2 > income Statement > operating Expenses

29035000

Quarters > 2 > income Statement > operating Income

-29035000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-27465000

Quarters > 2 > income Statement > net Income

-27483000

Quarters > 2 > income Statement > eps

-0.5482767197670964

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

50126148

Quarters > 2 > income Statement > income Tax Expense

18000

Quarters > 2 > income Statement > EBITDA

-28744000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1570000

Quarters > 2 > balance Sheet > cash

38226000

Quarters > 2 > balance Sheet > short Term Investments

89765000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

134517000

Quarters > 2 > balance Sheet > property Plant Equipment

20116000

Quarters > 2 > balance Sheet > total Assets

155401000

Quarters > 2 > balance Sheet > payables

2006000

Quarters > 2 > balance Sheet > short Term Debt

3172000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

27435000

Quarters > 2 > balance Sheet > equity

127966000

Quarters > 2 > cash Flow > net Income

-27483000

Quarters > 2 > cash Flow > depreciation

291000

Quarters > 2 > cash Flow > change In Working Capital

423000

Quarters > 2 > cash Flow > cash From Operations

-23355000

Quarters > 2 > cash Flow > capital Expenditures

187000

Quarters > 2 > cash Flow > cash From Investing

29813000

Quarters > 2 > cash Flow > cash From Financing

96000

Quarters > 2 > cash Flow > net Change In Cash

6533000

Quarters > 2 > ratios > PE

-0.5482767197670964

Quarters > 2 > ratios > PB

2.5618133560477

Quarters > 2 > ratios > ROE

-21.4767985246081

Quarters > 2 > ratios > ROA

-17.68521438085984

Quarters > 2 > ratios > FCF

-23542000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

43

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1238000

Quarters > 3 > income Statement > cost Of Revenue

291000

Quarters > 3 > income Statement > gross Profit

-291000

Quarters > 3 > income Statement > operating Expenses

27516000

Quarters > 3 > income Statement > operating Income

-27807000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-25810000

Quarters > 3 > income Statement > net Income

-25834000

Quarters > 3 > income Statement > eps

-0.5203172255333685

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

49650480

Quarters > 3 > income Statement > income Tax Expense

24000

Quarters > 3 > income Statement > EBITDA

-25519000

Quarters > 3 > income Statement > operating Margin

-2246.1227786752825

Quarters > 3 > income Statement > total Other Income Expense Net

1997000

Quarters > 3 > balance Sheet > cash

31693000

Quarters > 3 > balance Sheet > short Term Investments

119401000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

160623000

Quarters > 3 > balance Sheet > property Plant Equipment

20594000

Quarters > 3 > balance Sheet > total Assets

182503000

Quarters > 3 > balance Sheet > payables

2304000

Quarters > 3 > balance Sheet > short Term Debt

3149000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

30533000

Quarters > 3 > balance Sheet > equity

151970000

Quarters > 3 > cash Flow > net Income

-25834000

Quarters > 3 > cash Flow > depreciation

291000

Quarters > 3 > cash Flow > change In Working Capital

-942000

Quarters > 3 > cash Flow > cash From Operations

-23952000

Quarters > 3 > cash Flow > capital Expenditures

299000

Quarters > 3 > cash Flow > cash From Investing

29695000

Quarters > 3 > cash Flow > cash From Financing

543000

Quarters > 3 > cash Flow > net Change In Cash

6286000

Quarters > 3 > ratios > PE

-0.5203172255333685

Quarters > 3 > ratios > PB

2.1366989484766727

Quarters > 3 > ratios > ROE

-16.99940777785089

Quarters > 3 > ratios > ROA

-14.155383747116485

Quarters > 3 > ratios > FCF

-24251000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-19.58885298869144

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.39628933653187715

Valuation > metrics > PB

2.75249947263942

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-16.67868791768528

Profitability > metrics > ROA

-15.359746061603573

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.21291656826262073

Risk > metrics > Interest Coverage

-93.02

Risk > final Score

-312

Risk > verdict

High

Liquidity > metrics > Current Ratio

33.30462020360219

Liquidity > metrics > Quick Ratio

33.30462020360219

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-322

Prev Risks > 1

-31

Prev Risks > 2

-322

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:15:12.319Z